Vacunas de COVID-19 Para Niños de 6 Meses a 5 Años Recibe Autorización Federal; Vacunas Desde de la Semana de Jun. 20

DOVER, DE (18 de Junio, 2022) – Los padres de niños de 6 meses a 5 años podrán vacunar a sus hijos contra el COVID-19 a partir de la semana del 20 de Junio de 2022, según la División de Salud Pública (DPH). Las vacunas para este grupo de edad más joven recibieron la aprobación final para la Autorización de Uso de Emergencia de la Administración de Alimentos y Medicamentos (FDA) el Viernes y los Centros para el Control y la Prevención de Enfermedades (CDC) hoy.

Tanto la vacuna de Moderna como la de Pfizer-BioNTech fueron autorizadas para este grupo de edad, con leves diferencias entre ambas. Moderna es una vacuna de una serie de dos dosis, que contiene una cuarta parte de la dosis para adultos, para niños de 6 meses a 5 años. La eficacia estimada varía según la edad. La vacuna de Pfizer es una serie primaria de tres dosis que es una décima parte de la dosis para adultos y está autorizada para niños de 6 meses a 4 años, ya que su vacuna para niños de 5 años ya está aprobada. Tiene una efectividad estimada del 80% después de la tercera dosis.

Los efectos secundarios fueron generalmente leves y no se identificaron efectos secundarios graves. Para Moderna, los efectos secundarios reportados con mayor frecuencia en todas las edades incluyeron dolor, enrojecimiento e hinchazón en el lugar de la inyección, fiebre e hinchazón/sensibilidad en las axilas en el lugar de la inyección. Los efectos secundarios de Pfizer incluyeron irritabilidad, disminución de apetito, fiebre, dolor de cabeza, escalofríos y dolor, sensibilidad, enrojecimiento e hinchazón en el lugar de la inyección.

DPH ha incluido una tabla conveniente en de.gov/youthvaccine que explica las diferencias entre las dos vacunas.

Los cargamentos iniciales de Pfizer y Moderna están programados para llegar a Delaware el lunes 20 de junio de 2022 y se enviarán a los proveedores médicos que ordenaron uno o ambos con anterioridad. No todos los proveedores pre-ordenaron la vacuna inicialmente. Aunque algunos proveedores pueden estar listos para comenzar a administrar tan pronto como el 21 de Junio de 2022, otros han indicado que comenzarán después. DPH recomienda encarecidamente que los padres se comuniquen con su proveedor de atención médica pediátrica para obtener detalles específicos sobre la programación y tiempo. Se alienta a los padres a visitar de.gov/youthvaccine para obtener una lista de proveedores que ofrecen vacunas. Los suministros y el acceso aumentarán a medida que avance la semana.

“Estamos increíblemente felices y con tranquilidad de que una vacuna COVID-19 ahora estará disponible para nuestra población más joven a partir de los 6 meses de edad,” dijo la Directora del DPH, la Dra. Karyl Rattay. “Reconocemos la preocupación que padres con niños pequeños han enfrentado esperando que la vacuna esté disponible mientras que buscan formas de proteger a los más pequeños de este virus. Esperamos que los padres consulten con el proveedor de su hijo o con el centro médico apropiado para determinar la mejor opción para ellos.”

Las vacunas estarán disponibles a través de pediatras/proveedores de atención primaria, clínicas DPH y Centros de Salud Calificados Federalmente. Además de las clínicas del DPH, algunos proveedores adicionales acordaron vacunar a los que no son pacientes. Esa información se agregará a de.gov/youthvaccine a medida que esté disponible.

Las farmacias también vacunarán a bebés y niños en este grupo de edad. Sin embargo, es importante que las familias sepan que no todos vacunarán a los niños menores de 3 años. Ubique las farmacias participantes en vaccines.gov. La base de datos agregó una función que permite que las farmacias ingresen la edad más baja en la que están dispuestas a vacunar y debería aparecer cuando los padres busquen una vacuna para este grupo de edad más joven.

Aunque niños y adolescentes suelen tener menos riesgo que los adultos de enfermarse gravemente o ser hospitalizados por COVID-19, durante el aumento de Omicron (Invierno de 2021-22), sus tasas de enfermedad aumentaron. Durante el aumento invernal de Omicron, los bebés y niños menores de 5 años fueron hospitalizados con el virus a una tasa aproximadamente cinco veces más alta que durante el aumento de Delta (otoño de 2021), según un hallazgo reciente de un estudio de los Centros para el Control y la Prevención de Enfermedades (CDC). Adicionalmente, los resultados graves de COVID-19 son impredecibles y pueden ocurrir en niños sanos. El riesgo es mayor en aquellos con condiciones de salud subyacentes. Según datos del CDC, el 64% de las hospitalizaciones en menores de 5 años se da en aquellos sin comorbilidades. Por último, el COVID-19 puede causar enfermedades adicionales a largo plazo en niños. Entre tres y seis por ciento de los niños con COVID-19 se reportan síntomas continuos durante más de 12 semanas.

Los padres o guardianes que tengan preguntas sobre qué vacuna es adecuada para su hijo deben consultar a su proveedor pediátrico o médico de familia/proveedor de atención médica. Se anticipa que la mayoría de los padres acudirán a proveedores pediátricos para vacunar a bebés y niños en este grupo de edad.


COVID-19 Vaccines For Children 6 Months to 5 Years Receives Federal Authorization; DE Vaccines to Begin Week of June 20

DOVER, DE (June 18, 2022) – Parents of children ages 6 months through 5 years old, will be able to get their children vaccinated against COVID-19 starting the week of June 20, 2022, according to the Division of Public Health (DPH). Vaccines for this youngest age group received final sign off for Emergency Use Authorization, from the Food and Drug Administration (FDA) Friday, and the Centers for Disease Control and Prevention (CDC) today.

Both Moderna and Pfizer-BioNTech vaccines were authorized for this age group, with slight differences between the two. Moderna’s is a two-dose series of vaccine, which is one-quarter the adult dosage, for children ages 6 months through 5 years old.  Estimated effectiveness varies based on age. The Pfizer vaccine is a three-dose primary series that is one-tenth the adult dosage and is authorized for children 6 months through 4 years old, as their vaccine for 5-year-olds is already approved. It has an estimated effectiveness of 80% after the third dose.

Side effects were generally mild, and no serious side effects were identified. For Moderna, the most commonly reported side effects across all ages included pain, redness and swelling at the injection site, fever and underarm swelling/tenderness at the injection site. For Pfizer side effects included irritability, decreased appetite, fever, headache, chills and pain, tenderness, redness and swelling at the injection site.

DPH has included a convenient chart on de.gov/youthvaccine explaining the differences between the two vaccines.

Initial shipments of Pfizer and Moderna are set to arrive in Delaware on Monday, June 20, 2022, and are going to medical providers who pre-ordered either one, or both of them. Not all providers pre-ordered vaccine initially. While some providers may be ready to start administering as soon as June 21, 2022, others have indicated they will begin later. DPH strongly recommends that parents contact their pediatric health care provider for specifics on scheduling and timing.  Parents are encouraged to visit de.gov/youthvaccine for a list of providers offering vaccines. Supply and access will increase as the week goes on.

“We are incredibly happy and relieved that a COVID-19 vaccine will now be available to our youngest population starting at 6 months old,” said DPH Director Dr. Karyl Rattay.  “We recognize the concern that parents with young children have faced waiting for the vaccine to become available as they look for ways to protect their youngest from this virus.  It is our hope that parents will consult with their child’s provider or the appropriate medical facility to determine the best option for them.”

Vaccines will be available from pediatricians/primary care providers, DPH clinics, and Federally Qualified Health Centers. In addition to DPH clinics, a few additional providers have agreed to vaccinate non-patients. That information will be added to de.gov/youthvaccine as it becomes available.

Pharmacies will also vaccinate infants and children in this age group. However, it is important for families to know that not all will vaccinate children under age 3. Locate participating pharmacies at vaccines.gov. The database has added a feature which allows pharmacies to enter the lowest age they are willing to vaccinate and should show up when parents search for a vaccine for this youngest age group.

While children and adolescents are typically at lower risk than adults of becoming severely ill or hospitalized from COVID-19, during the Omicron surge (Winter 2021-22), their rates of illness increased. During the winter Omicron surge, infants and children under 5 years of age were hospitalized with the virus at approximately five times the rate they were during the Delta surge (Fall 2021), a study from the Centers for Disease Control and Prevention (CDC) recently found. Additionally, severe COVID-19 outcomes are unpredictable and can occur in healthy children. The risk is higher in those with underlying health conditions.  According to data from the CDC, 64% of hospitalizations in children under 5 years occur in those without comorbidities. Lastly, COVID-19 can cause additional long-term illness in children. Between three and six percent of children with COVID-19 report continued symptoms for more than 12 weeks.

Parents or guardians with questions about which vaccine is right for their child should consult their pediatric provider or family doctor/health care provider. It is anticipated that most parents will turn to pediatric providers to vaccinate infants and children in this age group.


COVID-19 Cases, Hospitalizations Decline; Guidance For Those Who Want To Wear Masks Included

DOVER, DE (March 4, 2022) – With new positive cases and hospitalizations continuing to decline in Delaware, mask mandates for schools and state buildings were lifted earlier this week across the state, consistent with updated guidance from the Centers for Disease Control and Prevention (CDC). The CDC guidance is based on county or community levels of spread and the level of hospitalizations. Even with the end of mask mandates, there are times when it is still recommended or even required, to wear a mask:

  • During isolation and quarantine per CDC guidance (recommended)
  • In hospitals and certain other health care facilities, long-term care facilities and public transportation (required)

The Division of Public Health (DPH) reminds the public that people may choose to mask at any time, and encourages you to consider your personal risk for contracting or serious outcomes from the virus when making the decision.

Consider masking up:

·        If you are unvaccinated, including children ages 2 through 4

·        If you are immunocompromised, or live, work or are visiting someone who is

·        If you are at higher risk for severe illness (older and pregnant people)

·        When community levels of COVID are high (see CDC County Check tool)

DPH is providing an update on the most recent statistics related to coronavirus disease 2019 (COVID-19) in Delaware, as of Thursday, March 3, 2022.

COVID-19 Cases and Hospitalizations:

  • Total positive cases since March 11, 2020: 257,065
  • 7-day average of new positive cases: 102.9, a decrease of 24.1 cases from last week.
  • 7-day average for the percentage of total positive tests: 4.2%, a decrease of 0.8 percentage points from last week.
  • Hospitalizations: 76, a decrease of 22 from last week; critically ill: 9, a decrease of 2 from last week.
  • Total COVID-19 deaths: 2,713.

  • Total COVID-19 deaths reported since last week: 7, including 2 from a review of vital statistics records.

COVID-19 Vaccinations:

  • Total number of doses administered in Delaware: 1,693,944
  • Percentage of Delawareans 5+ who are fully vaccinated (CDC data): 71.7%
  • Percentage of Delawareans 12+ who are fully vaccinated (CDC data): 76.1%
  • Percentage of Delawareans 18+ who are fully vaccinated (CDC data): 77.6%
  • Percent of Delawareans who are fully vaccinated (CDC data): 67.7%

All qualifying Delawareans should get vaccinated. Individuals who qualify for a booster dose should get one as soon as possible. Booster vaccinations are available at any locations that offer the initial COVID-19 vaccine series. Visit de.gov/boosters for more information. For the latest information on the COVID-19 vaccine in Delaware, visit de.gov/getmyvaccine. Delaware’s latest COVID-19 vaccination statistics can be found under the Vaccine Tracker dashboard at de.gov/healthycommunity.

COVID-19 Case Vaccination Status Report:  

The following reports capture a weekly breakdown of vaccination status for cases, deaths, and hospitalizations for the time frame for Feb. 21 – Feb. 27.

Weekly Overview
(2/21/22 – 2/27/22)

Unvaccinated Cases

Total Unvaccinated / Partially Vaccinated Cases

380

Total Cases

727

Percent of Unvaccinated / Partially Vaccinated Cases

52%

Hospitalizations

Unvaccinated / Partially Vaccinated Hospitalized Cases

25

Total Hospitalized Cases

41

Percent of Unvaccinated / Partially Vaccinated Hospitalized Cases

61%

Deaths

Unvaccinated / Partially Vaccinated COVID-19 Deaths

8

Total COVID-19 Deaths

9

Percent of Unvaccinated / Partially Vaccinated COVID-19 Deaths

89%

Weekly Overview
(2/21/22 – 2/27/22)

Non-boosted Cases

Total Non-boosted Cases

573

Total Cases

727

Percent of Non-boosted Cases

79%

Non-boosted Hospitalized Cases

Total Non-boosted Hospitalized Cases

34

Total Hospitalized Cases

41

Percent of Non-boosted Cases

83%

Non-boosted Deaths

Total Non-boosted Deaths

9

Total COVID-19 Deaths

9

Percent of Non-boosted Cases

100%

Breakthrough Cases:

DPH will no longer provide breakthrough case updates in the weekly press releases.  The weekly summary of the vaccination status and non-boosted cases are better indicators of effectiveness of vaccines in preventing disease, hospitalizations and deaths.  Breakthrough information that is cumulative since vaccine rollout began can be found on the Overview section (landing page) of My Healthy Community: https://myhealthycommunity.dhss.delaware.gov/locations/state.  Data is updated every Friday.

Long-term Care Statistics:

As of Thursday, March 3, there have been a total of 3,353 positive COVID-19 cases involving long-term care residents, and 914 residents of Delaware long-term care facilities have died from complications related to COVID-19.

Flu Update:

There were 29 laboratory-confirmed cases reported the week of Feb. 20 – Feb. 26. As of Feb. 26, 2022, the most recent date for which flu statistics are available, there have been 687 laboratory-confirmed cases for the current season. The cases involved 449 individuals from New Castle County, 92 from Kent County and 146 from Sussex County. This number reflects only the number of lab-confirmed cases; the actual number of cases circulating statewide is likely higher as not all people with the flu seek treatment, and many cases are diagnosed through rapid test kits in a provider’s office versus a lab.

All individuals 6 months and older are strongly encouraged to get vaccinated against the flu if they haven’t already. Flu vaccines are available at pharmacies (including those in grocery stores), participating medical provider offices, Federally Qualified Health Centers (for their patients), as well as Division of Public Health clinics. DPH is also advising the public that the flu vaccine can be administered at the same time as the COVID-19 vaccine.

For the latest information on the flu in Delaware, visit flu.delaware.gov.

Resources:

Individuals with general questions about COVID-19 should call Delaware 2-1-1, individuals who are deaf or hard of hearing can text their ZIP code to 898-211, or email delaware211@uwde.org. Hours of operation are:

Monday – Friday: 8:00 a.m. to 9:00 p.m.

Saturday: 9:00 a.m. to 5:00 p.m.

Medically related questions regarding testing, symptoms, and health-related guidance can be submitted by email at DPHCall@delaware.gov.

Delawareans 18 or older are encouraged to download COVID Alert DE, Delaware’s free exposure notification app to help protect your neighbors while ensuring your privacy. Download on the App Store or Google Play.

DPH will continue to update the public as more information becomes available. For the latest on Delaware’s response, go to de.gov/coronavirus.

###

Anyone who is deaf, hard of hearing, Deaf-Blind or speech disabled can contact DPH by dialing 711 first using specialized devices (i.e., TTY, TeleBraille, voice devices). The 711 service is free and to learn more about how it works, please visit delawarerelay.com.

 

The Delaware Department of Health and Social Services is committed to improving the quality of the lives of Delaware’s citizens by promoting health and well-being, fostering self-sufficiency, and protecting vulnerable populations.


DPH Launches QR Tool Giving Delawareans Convenient Access to Their COVID-19 Vaccine Record

DOVER, DE (Dec. 21, 2021) – The Delaware Division of Public Health (DPH) announced today that individuals vaccinated in Delaware will now have access to a QR code when downloading their COVID-19 vaccination record.

The digital COVID-19 vaccination card now includes the QR code and is available through the DelVAX Public Portal, a site where those who were vaccinated in Delaware can access their immunization records. When the person accesses their COVID-19 record they will be able to download a PDF version of it, which resembles a vaccine card and includes the QR Code. The image can then be saved to a phone gallery, or printed on paper.

The technology allows anyone to show proof of vaccination with a digital or printed QR code instead of a paper card. QR codes contain the same information as paper records, but in a format that offers greater security and efficiency. The QR code is digitally verified by the Delaware Division of Public Health.

“This new feature provides individuals convenient access to their COVID-19 vaccination record in a way that keeps their personal health information secure,” said DPH Director Dr. Karyl Rattay. “This offers a protected link to your COVID-19 vaccination record on the go.”

Businesses that choose to verify an individual’s vaccination status can scan QR codes using a SMART Health Card verifier app. Individuals do not need to download an app to obtain their QR code. When a business or entity scans the QR code, the vaccination information will only appear for a short period of time for verification purposes and will not be saved on the device, keeping the individual’s personal information secure.

Delaware is among several states to recently adopt the SMART Health Card Framework for QR codes, providing individuals with trustworthy and verifiable copies of their vaccination records in digital or paper form. The framework and standards for the technology were developed by VCI, a coalition of more than 800 public and private organizations – including The Mayo Clinic, Boston Children’s Hospital, Microsoft, MITRE, and The Commons Project Foundation.

QR codes are available to anyone whose vaccination record includes a working phone number and is in Delaware’s immunization database, DelVAX. Nearly all doses administered in Delaware are reported to DelVAX, including pharmacies, physician offices, Federally Qualified Health Centers, public health clinics and state-run community vaccination events. Some doses administered outside Delaware to Delaware residents may be in DelVAX. Doses administered directly by federal agencies such as the Department of Defense or Department of Veterans Affairs are not reported to DelVAX.

Parents and legal guardians can access official immunization records for their child/children age 0-17, and adults (age 18 years and older) can access official immunization records for themselves. DelVAX uses two-factor authentication via text messaging or email to validate patient, parent, or guardian access.

The DelVAX Public Portal is available at https://delvax.dhss.delaware.gov/delvax_public/Application/PublicPortal.

 

 

Individuals who need assistance can call 1-800-282-8672, or email DelVAX@delaware.gov.


Insurance Commissioner Navarro, Lt. Governor Hall-Long to Host Dover COVID Vaccine and Flu Shot Clinic

Local independent pharmacy to administer important immunizations

Insurance Commissioner Trinidad Navarro, in collaboration with Lieutenant Governor Bethany Hall-Long and Kevin Musto, R.Ph., FAPhA, independent pharmacist with Atlantic Apothecary, has announced a COVID Vaccination and Flu Shot Clinic on Thursday, November 18 from 1:00 to 4:00PM at the Delaware Department of Insurance’s Dover Office, 1351 West North Street. Weather permitting, the event will take place outdoors.

“Both the COVID-19 vaccines and the flu shot are safe and effective, and I’m proud to be able to offer them at our Dover office. Each are vital in helping to avoid significant illness, including hospitalization and death, and can be received during the same visit – including at our November 18 event,” said Commissioner Navarro, who will be getting his next dose of the COVID-19 vaccine at the event.Be A Virus Fighter Flyer

All three types of COVID-19 vaccines – Johnson & Johnson, Moderna, and Pfizer – will be available. Pfizer will be provided to eligible residents 5 years and older, Moderna is available for those 12 and older, and Johnson & Johnson for those 18 and older. All levels of vaccination will be offered, including first, second, third and booster doses. Flu shots are available and recommended for those 6 months and older. High-dose flu shots for those 65+ will also be administered at no charge with a Medicare card. Minors must have a guardian’s consent to receive their immunization.

Residents should bring their photo ID or other identification, insurance information or Medicare card, and their prescription or pharmacy card if applicable. Those who have previously received a dose of the COVID-19 vaccine should bring their vaccine card or other documentation if possible. Vaccinations records can be obtained via the DelVAX system. For a faster registration, flu shot recipients can download and complete their Influenza Fluzone form in advance. There is a separate Influenza Fluzone form for those 65+  who wish to receive the high-dose flu vaccine. Participants will be asked to wear a mask and observe social distancing protocols.

Commissioner Navarro also expressed his gratitude to the pharmacists who have been providing these important immunizations throughout the state, saying “This event, and so many others, wouldn’t be possible without local pharmacies and their dedicated staff. We are grateful for their service to our communities.”

For more information about the flu and where to get vaccinated, visit flu.delaware.gov or call 1-800-282-8672. For information about where to get the COVID-19 vaccine, visit coronavirus.delaware.gov/vaccine/where-can-i-get-my-vaccine/ or call 1-833-643-1715.

COVID-19 vaccination eligibility for Johnson and Johnson second dose, third and booster doses of Moderna and Pfizer, and age-based eligibility for vaccination are all subject to change prior to the event. More information on COVID-19 vaccine doses is available through the Delaware Division of Health.

View event flyer or email Christina.Haas@Delaware.gov  for a full-size flyer.

NOTE TO MEDIA: Media availability will be at 3PM. If you plan to attend, please RSVP to Christina.Haas@Delaware.gov.